Optimizing Peptide Synthesis: The Role of Fmoc-N-Me-Tyr(tBu)-OH
In the intricate world of peptide synthesis, selecting the right building blocks is paramount for achieving desired outcomes. Among the myriad of protected amino acids available, Fmoc-N-Me-Tyr(tBu)-OH stands out as a critical component for researchers aiming to construct complex and modified peptide sequences. As a leading manufacturer and supplier, we understand the importance of high-quality reagents like this specialized tyrosine derivative, CAS 133373-24-7, for your demanding projects.
Fmoc-N-Me-Tyr(tBu)-OH, also known as N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-alpha-methyl-O-t-butyl-L-tyrosine, offers several distinct advantages. The inclusion of an N-methyl group on the alpha-amino nitrogen and a tert-butyl protecting group on the phenolic hydroxyl of tyrosine introduces unique properties. These modifications can significantly impact the solubility, stability, and biological activity of the resulting peptides. For instance, the N-methylation can alter peptide conformation and resistance to enzymatic degradation, making it a valuable strategy in developing more robust therapeutic peptides.
The Fmoc (9-fluorenylmethyloxycarbonyl) group serves as a base-labile protecting group for the alpha-amino nitrogen. This is a cornerstone of the widely adopted Solid Phase Peptide Synthesis (SPPS) methodology. Its orthogonal deprotection strategy, typically employing piperidine, allows for selective deprotection and coupling cycles without affecting other protecting groups, such as the acid-labile tert-butyl group on the tyrosine side chain. This precise control is essential when building peptides with specific sequences and modifications.
Researchers often seek to buy Fmoc-N-Me-Tyr(tBu)-OH 133373-24-7 for its utility in creating peptide libraries for drug discovery. These libraries are screened for potential therapeutic agents, and the incorporation of modified amino acids like N-methylated tyrosine can lead to novel pharmacological properties. As a dedicated supplier in China, we ensure that our product meets the high standards required for these critical applications. Understanding the Fmoc-N-Me-Tyr(tBu)-OH price for peptide synthesis is key for budget planning, and we strive to offer competitive pricing for this essential intermediate.
Furthermore, this derivative is invaluable in various fields beyond basic peptide synthesis. In drug development, it contributes to the creation of peptide-based drugs that require enhanced stability and pharmacokinetic profiles. For those involved in bioconjugation, Fmoc-N-Me-Tyr(tBu)-OH can be integrated into peptides destined for conjugation to antibodies or other carriers, improving drug delivery systems. Its role in proteomics research is also growing, as scientists investigate the functional consequences of post-translational modifications, including methylation.
When sourcing this critical reagent, partnering with a reputable CAS 133373-24-7 manufacturer is vital. We are committed to providing consistent quality and reliable supply, supporting your research and development efforts. Whether you need small quantities for initial screening or larger batches for scale-up, our focus is on delivering excellence. For inquiries about purchasing this product or to obtain a quote, please contact us. We are dedicated to being your trusted source for advanced peptide synthesis materials.
Perspectives & Insights
Chem Catalyst Pro
“The inclusion of an N-methyl group on the alpha-amino nitrogen and a tert-butyl protecting group on the phenolic hydroxyl of tyrosine introduces unique properties.”
Agile Thinker 7
“These modifications can significantly impact the solubility, stability, and biological activity of the resulting peptides.”
Logic Spark 24
“For instance, the N-methylation can alter peptide conformation and resistance to enzymatic degradation, making it a valuable strategy in developing more robust therapeutic peptides.”